EconomyLens.com
No Result
View All Result
Sunday, September 13, 2026
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials
EconomyLens.com
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials
No Result
View All Result
EconomyLens.com
No Result
View All Result
Home Business

Bosses resign at Japan supplement firm probing deaths

Andrew Murphy by Andrew Murphy
July 22, 2024
in Business
Reading Time: 4 mins read
A A
4
32
SHARES
399
VIEWS
Share on FacebookShare on Twitter

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (2nd L) and others bow their heads at a press conference in Osaka in March as the firm faces a health scare linked to its over-the-counter tablets containing red yeast rice. ©AFP

Tokyo (AFP) – The chairman and president of a major Japanese dietary supplement maker announced their resignation on Tuesday, as the company probes 80 deaths potentially linked to tablets meant to lower cholesterol.

Related

French IT giant Capgemini sells subsidiary after row over ICE links

Czech antitrust office lets Turkey’s Pegasus Airlines buy Smartwings

Musk threatens legal action over documentary

Deals worth billions to be signed as UAE leader visits Germany

Heat forces French champagne makers to stiffen their drink

Kobayashi Pharmaceutical is at the centre of a health scare linked to its over-the-counter tablets containing red yeast rice, which is fermented with a mould culture. Medical studies say red yeast rice or “beni koji” can improve cholesterol levels but also warn of a risk of organ damage depending on the ingredient’s chemical make-up.

A company statement said president Akihiro Kobayashi and chairman Kazumasa Kobayashi were leaving their posts. Both men belong to the firm’s founding family. The decision was made “to clarify executive responsibility over a series of actions by our company related to the ‘beni koji’ issue”, Kobayashi Pharmaceutical said.

Red yeast rice has been used in food, alcoholic drinks and folk medicine for centuries around East Asia. The scandal erupted in March when the company, a household name in Japan, recalled three brands of dietary supplements after customers complained of kidney problems. It later said it had detected a potentially toxic acid produced by the mould at one of its factories, and the government inspected the firm’s facilities. Last month, the company said it was probing a total of 80 deaths possibly connected to its pills, and investigating whether organs other than kidneys were harmed. But at the time the government called Kobayashi Pharmaceutical’s delay in reporting the number of cases under investigation “extremely regrettable”.

On Tuesday, the company’s board of directors said in a separate statement that they “pray for the souls of those who died…and offer condolences to the bereaved families”. The company’s new president is Satoshi Yamane, previously head of sustainability policy, the company said. Outgoing president Akihiro Kobayashi, who has expressed his intention to take responsibility for any harm caused, will remain in an executive role to manage compensation-related matters, it added.

Kobayashi’s red yeast rice supplements are regulated under a system created in 2015 under former premier Shinzo Abe. Some watchdogs have reportedly expressed concerns that the regulation of these products is not sufficiently stringent and that they do not always have the advertised effects.

© 2024 AFP

Tags: health scarepharmaceuticalsresignation
Share13Tweet8Share2Pin3Send
Previous Post

Theme park’s novel bid to fix South Korea youth unemployment

Next Post

Markets mixed after US rally ahead of inflation report

Andrew Murphy

Andrew Murphy

Related Posts

Business

Cyberattack ruled out in UK air traffic glitch as more flights axed

September 9, 2026
Business

Zara owner Inditex boosts profits as sales grow across board

September 9, 2026
Business

Travellers in UK face more chaos after air traffic control glitch

September 9, 2026
Business

From trenches to catwalk: Ukraine’s amputee soldiers hit the runway

September 9, 2026
Business

LIV Golf files for bankruptcy protection

September 8, 2026
Business

Nearly 1,100 flights cancelled after UK air traffic control glitch

September 8, 2026
Next Post

Markets mixed after US rally ahead of inflation report

India on $24 bn jobs drive in Modi's first post-election budget

Stocks diverge tracking US election battle, earnings

EU opens probe into possible online food-delivery cartel

0 0 votes
Article Rating
Subscribe
Notify of
guest
guest
4 Comments
Oldest
Newest Most Voted
  • Trending
  • Comments
  • Latest

New York ruling deals Trump business a major blow

September 30, 2024

Elon Musk’s X fights Australian watchdog over church stabbing posts

April 21, 2024

Women journalists bear the brunt of cyberbullying

April 22, 2024

France probes TotalEnergies over 2021 Mozambique attack

May 6, 2024

New York ruling deals Trump business a major blow

104

Ghanaian finance ministry warns against fallout from anti-LGBTQ law

74

Shady bleaching jabs fuel health fears, scams in W. Africa

71

Stock markets waver, oil prices edge up

65

Lights out in Laos as electricity exports surge

September 12, 2026

‘This is the test’: All eyes on US Fed to tackle high inflation

September 13, 2026

Ukraine’s economy hobbled by Russian strikes

September 13, 2026

‘Great to have a race at home’: Fans celebrate F1’s Madrid return

September 12, 2026
EconomyLens Logo

We bring the world economy to you. Get the latest news and insights on the global economy, from trade and finance to technology and innovation.

Your Privacy Choices

Pages

  • Home
  • About Us
  • Privacy Policy
  • Contact Us

Categories

  • Business
  • Economy
  • Markets
  • Tech
  • Editorials

Network

  • Coolinarco.com
  • CasualSelf.com
  • Fit.CasualSelf.com
  • Sport.CasualSelf.com
  • SportBeep.com
  • MachinaSphere.com
  • MagnifyPost.com
  • TodayAiNews.com
  • VideosArena.com
© 2026 EconomyLens.com - Top economic news from around the world.
No Result
View All Result
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials

© 2024 EconomyLens.com - Top economic news from around the world.